State of Alaska Department of Revenue lessened its stake in shares of Clorox Co (NYSE:CLX) by 50.0% during the third quarter, HoldingsChannel.com reports. The fund owned 79,436 shares of the company’s stock after selling 79,306 shares during the period. State of Alaska Department of Revenue’s holdings in Clorox were worth $11,944,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Exeter Financial LLC increased its stake in shares of Clorox by 3.9% in the 2nd quarter. Exeter Financial LLC now owns 9,719 shares of the company’s stock valued at $1,314,000 after purchasing an additional 367 shares during the last quarter. Oppenheimer Asset Management Inc. increased its stake in shares of Clorox by 1.6% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 23,638 shares of the company’s stock valued at $3,197,000 after purchasing an additional 383 shares during the last quarter. Global X Management Co LLC increased its stake in shares of Clorox by 6.0% in the 2nd quarter. Global X Management Co LLC now owns 6,899 shares of the company’s stock valued at $933,000 after purchasing an additional 391 shares during the last quarter. Advisor Partners LLC increased its stake in shares of Clorox by 10.8% in the 2nd quarter. Advisor Partners LLC now owns 4,172 shares of the company’s stock valued at $564,000 after purchasing an additional 408 shares during the last quarter. Finally, First Midwest Bank Trust Division boosted its holdings in shares of Clorox by 2.5% during the 2nd quarter. First Midwest Bank Trust Division now owns 17,026 shares of the company’s stock valued at $2,303,000 after acquiring an additional 412 shares in the last quarter. Hedge funds and other institutional investors own 78.36% of the company’s stock.

Several research firms recently weighed in on CLX. Deutsche Bank downgraded Clorox from a “hold” rating to a “sell” rating and set a $123.00 price objective on the stock. in a report on Wednesday. Barclays set a $131.00 price objective on Clorox and gave the company a “hold” rating in a report on Saturday, October 6th. Zacks Investment Research downgraded Clorox from a “buy” rating to a “hold” rating in a report on Friday, October 5th. Argus raised Clorox from a “hold” rating to a “buy” rating and set a $175.00 price objective on the stock in a report on Tuesday, September 25th. Finally, ValuEngine raised Clorox from a “hold” rating to a “buy” rating in a report on Saturday, September 22nd. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $137.21.

In other Clorox news, EVP Laura Stein sold 12,880 shares of Clorox stock in a transaction dated Friday, August 31st. The stock was sold at an average price of $144.10, for a total transaction of $1,856,008.00. Following the transaction, the executive vice president now directly owns 74,483 shares of the company’s stock, valued at approximately $10,733,000.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Michael R. Costello sold 9,265 shares of Clorox stock in a transaction dated Monday, August 13th. The stock was sold at an average price of $140.02, for a total value of $1,297,285.30. Following the transaction, the senior vice president now directly owns 34,293 shares in the company, valued at $4,801,705.86. The disclosure for this sale can be found here. Insiders have sold a total of 29,268 shares of company stock worth $4,196,686 over the last ninety days. Company insiders own 1.00% of the company’s stock.

NYSE CLX opened at $147.55 on Thursday. The company has a debt-to-equity ratio of 3.15, a quick ratio of 0.67 and a current ratio of 1.09. Clorox Co has a twelve month low of $113.57 and a twelve month high of $153.38. The firm has a market cap of $19.21 billion, a P/E ratio of 23.57, a PEG ratio of 3.11 and a beta of 0.36.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, August 2nd. The company reported $1.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.58 by $0.08. The firm had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.72 billion. Clorox had a return on equity of 103.18% and a net margin of 13.44%. The business’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.53 EPS. On average, analysts forecast that Clorox Co will post 6.41 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, November 16th. Shareholders of record on Wednesday, October 31st will be issued a dividend of $0.96 per share. This represents a $3.84 annualized dividend and a yield of 2.60%. The ex-dividend date of this dividend is Tuesday, October 30th. Clorox’s payout ratio is presently 61.34%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: What is an Initial Public Offering (IPO)?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.